We are analyzing https://link.springer.com/article/10.1007/s00702-011-0684-8.

Title:
Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy | Journal of Neural Transmission
Description:
Angiogenesis has not been extensively studied in Parkinson’s disease (PD) despite being associated with other neurodegenerative disorders. Post-mortem human brain tissues were obtained from subjects with pathologically confirmed Parkinson’s disease (PD) and progressive supranuclear palsy (PSP), a rapidly progressing Parkinsonian-like disorder. Tissues were also obtained from subjects with incidental Lewy body disease (iLBD) who had Lewy bodies in the substantia nigra pars compacta (SNpc) but had not been diagnosed with PD, and age-matched controls without Lewy body pathology. The SNpc, putamen, locus ceruleus (LC) and midfrontal cortex were examined for integrin αvβ3, a marker for angiogenesis, along with vessel number and activated microglia. All parkinsonian syndromes had greater αvβ3 in the LC and the SNpc, while only PD and PSP subjects had elevated αvβ3 in the putamen compared to controls. PD and PSP subjects also had increases in microglia number and activation in the SNpc suggesting a link between inflammation and clinical disease. Microglia activation in iLBD subjects was limited to the LC, an area involved at an early stage of PD. Likewise, iLBD subjects did not differ from controls in αvβ3 staining in the putamen, a late area of involvement in PD. The presence of αvβ3 reactive vessels in PD and its syndromes is indicative of newly created vessels that have not likely developed the restrictive properties of the blood brain barrier. Such angiogenic vessels could contribute to neuroinflammation by failing to protect the parenchyma from peripheral immune cells and inflammatory or toxic factors in the peripheral circulation.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

Education
Health & Fitness
Science

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month

Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We don't see any clear sign of profit-making.

Some websites aren't about earning revenue; they're built to connect communities or raise awareness. There are numerous motivations behind creating websites. This might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

google, scholar, pubmed, article, cas, disease, parkinsons, angiogenesis, sisters, chicago, palsy, schneider, progressive, supranuclear, alzheimers, brain, vessels, neurol, neural, lewy, subjects, integrin, activation, blood, angiogenic, vascular, body, pathology, microglia, barrier, model, cell, incidental, carvey, hendey, αvβ, access, transm, endothelial, bennett, expression, rush, privacy, cookies, content, journal, desai, mouse, mcgeer, study,

Topics {✒️}

4-dihydroxyphenyl-l-alanine-induced dyskinesia l-dopa-induced angiogenic activity month download article/chapter pigment epithelium-derived factor clinic-based cohort study steele-richardson-olszewski syndrome dual-targeted contrast agent blood-brain barrier permeability hypoxia-induced integrin activation age-related cognitive decline α-synuclein pathology community-dwelling older persons progressive supranuclear palsy full article pdf striatal l-dopa l-dopa-carbidopa lewy body pathology community-based studies privacy choices/manage cookies alpha-synuclein deposition nigral dopaminergic neurons cohn research building blood brain barrier blood-brain barrier endothelial cell activation vascular integrin alpha alpha-synuclein pathology kenneth douglas foundation brooks pc carvey pm extracellular dopamine levels 6-hydroxydopamine-induced alterations peptide induced eae heterogeneous degeneration involving religious orders study hypoxia-induced retinopathy levodopa-induced dyskinesias brain blood vessels disease-related pathology parkinsonian substantia nigra endothelial cell proliferation check access instant access decision rules guiding vulnerable neuronal types 6-hydroxydopamine lesioned rats targeted proapoptotic peptidomimetic oligodendrocyte precursor differentiation abdominal aortic aneurysm 6-hydroxydopamine-lesioned rats

Questions {❓}

Horton M (1990) Vitronectin receptor: tissue specific expression or adaptation to culture?
Kirk S, Frank JA, Karlik S (2004) Angiogenesis in multiple sclerosis: is it good, bad or an epiphenomenon?
Streit WJ (2006) Microglial senescence: does the brain’s immune system have an expiration date?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy
         description:Angiogenesis has not been extensively studied in Parkinson’s disease (PD) despite being associated with other neurodegenerative disorders. Post-mortem human brain tissues were obtained from subjects with pathologically confirmed Parkinson’s disease (PD) and progressive supranuclear palsy (PSP), a rapidly progressing Parkinsonian-like disorder. Tissues were also obtained from subjects with incidental Lewy body disease (iLBD) who had Lewy bodies in the substantia nigra pars compacta (SNpc) but had not been diagnosed with PD, and age-matched controls without Lewy body pathology. The SNpc, putamen, locus ceruleus (LC) and midfrontal cortex were examined for integrin αvβ3, a marker for angiogenesis, along with vessel number and activated microglia. All parkinsonian syndromes had greater αvβ3 in the LC and the SNpc, while only PD and PSP subjects had elevated αvβ3 in the putamen compared to controls. PD and PSP subjects also had increases in microglia number and activation in the SNpc suggesting a link between inflammation and clinical disease. Microglia activation in iLBD subjects was limited to the LC, an area involved at an early stage of PD. Likewise, iLBD subjects did not differ from controls in αvβ3 staining in the putamen, a late area of involvement in PD. The presence of αvβ3 reactive vessels in PD and its syndromes is indicative of newly created vessels that have not likely developed the restrictive properties of the blood brain barrier. Such angiogenic vessels could contribute to neuroinflammation by failing to protect the parenchyma from peripheral immune cells and inflammatory or toxic factors in the peripheral circulation.
         datePublished:2011-07-12T00:00:00Z
         dateModified:2011-07-12T00:00:00Z
         pageStart:59
         pageEnd:71
         sameAs:https://doi.org/10.1007/s00702-011-0684-8
         keywords:
            Angiogenesis
            Parkinson’s disease
            Incidental Lewy body disease
            Progressive supranuclear palsy
            Integrin αvβ3
            Microglia
            Neurology
            Psychiatry
            Neurosciences
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig1_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig2_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig3_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig4a_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig4b_HTML.gif
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig5_HTML.gif
         isPartOf:
            name:Journal of Neural Transmission
            issn:
               1435-1463
               0300-9564
            volumeNumber:119
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Vienna
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Brinda Desai Bradaric
               affiliation:
                     name:Rush University
                     address:
                        name:Department of Pharmacology, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Aditiben Patel
               affiliation:
                     name:Rush University
                     address:
                        name:Department of Pharmacology, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Julie A. Schneider
               affiliation:
                     name:Rush University
                     address:
                        name:Rush Alzheimer’s Disease Center, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
                     name:Rush University
                     address:
                        name:Department of Neurological Sciences, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
                     name:Rush University
                     address:
                        name:Department of Pathology, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Paul M. Carvey
               affiliation:
                     name:Rush University
                     address:
                        name:Department of Pharmacology, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
                     name:Rush University
                     address:
                        name:Department of Neurological Sciences, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Bill Hendey
               affiliation:
                     name:Rush University
                     address:
                        name:Department of Pharmacology, Rush University, Chicago, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:
         hasPart:
            isAccessibleForFree:
            cssSelector:.main-content
            type:WebPageElement
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Evidence for angiogenesis in Parkinson’s disease, incidental Lewy body disease, and progressive supranuclear palsy
      description:Angiogenesis has not been extensively studied in Parkinson’s disease (PD) despite being associated with other neurodegenerative disorders. Post-mortem human brain tissues were obtained from subjects with pathologically confirmed Parkinson’s disease (PD) and progressive supranuclear palsy (PSP), a rapidly progressing Parkinsonian-like disorder. Tissues were also obtained from subjects with incidental Lewy body disease (iLBD) who had Lewy bodies in the substantia nigra pars compacta (SNpc) but had not been diagnosed with PD, and age-matched controls without Lewy body pathology. The SNpc, putamen, locus ceruleus (LC) and midfrontal cortex were examined for integrin αvβ3, a marker for angiogenesis, along with vessel number and activated microglia. All parkinsonian syndromes had greater αvβ3 in the LC and the SNpc, while only PD and PSP subjects had elevated αvβ3 in the putamen compared to controls. PD and PSP subjects also had increases in microglia number and activation in the SNpc suggesting a link between inflammation and clinical disease. Microglia activation in iLBD subjects was limited to the LC, an area involved at an early stage of PD. Likewise, iLBD subjects did not differ from controls in αvβ3 staining in the putamen, a late area of involvement in PD. The presence of αvβ3 reactive vessels in PD and its syndromes is indicative of newly created vessels that have not likely developed the restrictive properties of the blood brain barrier. Such angiogenic vessels could contribute to neuroinflammation by failing to protect the parenchyma from peripheral immune cells and inflammatory or toxic factors in the peripheral circulation.
      datePublished:2011-07-12T00:00:00Z
      dateModified:2011-07-12T00:00:00Z
      pageStart:59
      pageEnd:71
      sameAs:https://doi.org/10.1007/s00702-011-0684-8
      keywords:
         Angiogenesis
         Parkinson’s disease
         Incidental Lewy body disease
         Progressive supranuclear palsy
         Integrin αvβ3
         Microglia
         Neurology
         Psychiatry
         Neurosciences
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig1_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig2_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig3_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig4a_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig4b_HTML.gif
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00702-011-0684-8/MediaObjects/702_2011_684_Fig5_HTML.gif
      isPartOf:
         name:Journal of Neural Transmission
         issn:
            1435-1463
            0300-9564
         volumeNumber:119
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Vienna
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Brinda Desai Bradaric
            affiliation:
                  name:Rush University
                  address:
                     name:Department of Pharmacology, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Aditiben Patel
            affiliation:
                  name:Rush University
                  address:
                     name:Department of Pharmacology, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Julie A. Schneider
            affiliation:
                  name:Rush University
                  address:
                     name:Rush Alzheimer’s Disease Center, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
                  name:Rush University
                  address:
                     name:Department of Neurological Sciences, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
                  name:Rush University
                  address:
                     name:Department of Pathology, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Paul M. Carvey
            affiliation:
                  name:Rush University
                  address:
                     name:Department of Pharmacology, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
                  name:Rush University
                  address:
                     name:Department of Neurological Sciences, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Bill Hendey
            affiliation:
                  name:Rush University
                  address:
                     name:Department of Pharmacology, Rush University, Chicago, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:
      hasPart:
         isAccessibleForFree:
         cssSelector:.main-content
         type:WebPageElement
["Periodical","PublicationVolume"]:
      name:Journal of Neural Transmission
      issn:
         1435-1463
         0300-9564
      volumeNumber:119
Organization:
      name:Springer Vienna
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Rush University
      address:
         name:Department of Pharmacology, Rush University, Chicago, USA
         type:PostalAddress
      name:Rush University
      address:
         name:Department of Pharmacology, Rush University, Chicago, USA
         type:PostalAddress
      name:Rush University
      address:
         name:Rush Alzheimer’s Disease Center, Rush University, Chicago, USA
         type:PostalAddress
      name:Rush University
      address:
         name:Department of Neurological Sciences, Rush University, Chicago, USA
         type:PostalAddress
      name:Rush University
      address:
         name:Department of Pathology, Rush University, Chicago, USA
         type:PostalAddress
      name:Rush University
      address:
         name:Department of Pharmacology, Rush University, Chicago, USA
         type:PostalAddress
      name:Rush University
      address:
         name:Department of Neurological Sciences, Rush University, Chicago, USA
         type:PostalAddress
      name:Rush University
      address:
         name:Department of Pharmacology, Rush University, Chicago, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Brinda Desai Bradaric
      affiliation:
            name:Rush University
            address:
               name:Department of Pharmacology, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Aditiben Patel
      affiliation:
            name:Rush University
            address:
               name:Department of Pharmacology, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Julie A. Schneider
      affiliation:
            name:Rush University
            address:
               name:Rush Alzheimer’s Disease Center, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
            name:Rush University
            address:
               name:Department of Neurological Sciences, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
            name:Rush University
            address:
               name:Department of Pathology, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Paul M. Carvey
      affiliation:
            name:Rush University
            address:
               name:Department of Pharmacology, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
            name:Rush University
            address:
               name:Department of Neurological Sciences, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
      name:Bill Hendey
      affiliation:
            name:Rush University
            address:
               name:Department of Pharmacology, Rush University, Chicago, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Department of Pharmacology, Rush University, Chicago, USA
      name:Department of Pharmacology, Rush University, Chicago, USA
      name:Rush Alzheimer’s Disease Center, Rush University, Chicago, USA
      name:Department of Neurological Sciences, Rush University, Chicago, USA
      name:Department of Pathology, Rush University, Chicago, USA
      name:Department of Pharmacology, Rush University, Chicago, USA
      name:Department of Neurological Sciences, Rush University, Chicago, USA
      name:Department of Pharmacology, Rush University, Chicago, USA
WebPageElement:
      isAccessibleForFree:
      cssSelector:.main-content

External Links {🔗}(236)

Analytics and Tracking {📊}

Google Tag Manager

Libraries {📚}

Clipboard.js
Prism.js

CDN Services {📦}

Crossref

4.45s.

LINK . SPRINGER . COM {}